ABSTRACT & COMMENTARY

SARS-CoV-2 Infection During Pregnancy and Increased Risk of Preeclampsia

November 1, 2021

A meta-analysis of 28 observational studies found that having SARS-CoV-2 infection during pregnancy was associated with a 58% increase in the adjusted odds of having preeclampsia compared to those without SARS-CoV-2 infection during pregnancy.

Issue Date: November 1, 2021

Table of Contents

Financial Disclosure: Dr. Rebecca H. Allen (editor) reports that she receives grant/research support from Bayer and is a consultant for Bayer, Mylan, and Merck. Dr. Sarah J. Betstadt (peer reviewer) reports that she is on the speakers bureau for Merck. All of the relevant financial relationships listed for these individuals have been mitigated. None of the remaining planners or authors for this educational activity have relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Subscription Publication Books & Study Guides Group & Site Licenses State CME/CE Requirements